Search clinical trials for: Keppra® in Children

Total 458028 results

UCB Pharma

Completed

Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution

Epilepsy

France, Germany, Greece, Italy, Poland, Spain, United Kingdom
UCB Pharma

Completed

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

Epilepsy

Brazil, Finland, India, Mexico, Russian Federation, South Africa, Ukraine
UCB Pharma SA

Completed

Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Epilepsy

France, United States, Mexico, Turkey, Belgium, Germany
UCB Pharma

Completed

Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Epilepsy

France, United States, Belgium, Mexico, Turkey, Germany
Central DuPage Hospital
Zimmer Biomet; Halifax Biomedical Inc.

Unknown

A Prospective Radiostereometric Analysis and Clinical Evaluation of the Zimmer® Continuum® Acetabular Cup With Vitamin E Stabilized Polyethylene

Radiostereometric Analysis | Vitamin E Liner | Zimmer® Continuum® Acetabular Cup

United States
Semmes-Murphey Foundation

Unknown

Efficacy of Intradiscal Injection of Viable Placental Tissue Extract in Subjects With One or Two Level, Symptomatic Lumbar Intervertebral Disc Degeneration

Pain | Degenerative Disc Disease

United States
UCB Japan Co. Ltd.

Completed

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

Epilepsy | Partial Onset Seizures

Japan
UCB Japan Co. Ltd.

Completed

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Epilepsy | Generalized Tonic-Clonic Seizures

China, Japan
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.

Healthy

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions

Healthy

United States
Tianjin Medical University Cancer Institute and...

Recruiting

Bovine Pericardial Patch and TiLOOP® Bra Mesh in Immediate Implant Breast Reconstruction.

Implant Breast Reconstruction | TiLOOP® Bra Mesh | Bovine Pericardial Patch

China
Hospital de Base

Not yet recruiting

Diagnostic Accuracy Study of a Point-of-Care Test for Coagulation Function

CoaguChek® XS System | Coagulation Function
University of South Florida

Terminated

Keppra for Cervical Dystonia (Keppra)

Cervical Dystonia
Allergan

Completed

Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System

Patients Who Participated in an Intravitreal Brimo PS DDS® Study

France, United Kingdom, Korea, Republic of, Czech Republic, Australia, Israel, India, Portugal, Germany, United States, Italy, Philippines
Johanna Maria Vermeulen
Nanjing University of Chinese Medicine; Mermaid Medicine®

Completed

Acupuncture for Nasal Congestion in Allergic Rhinitis (ANCAR)

Allergic Rhinitis

Netherlands
Pierre Fabre Dermo Cosmetique

Completed

Sunscreen Efficacy Against the Reccurence of Lesions Post-sun Exposure in Acneic Subjects

Acne

Portugal
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Non-Fasting Conditions

Healthy

United States
Central Clinical Hospital of the Ministry of Internal...

Completed

First-in-man Sirolimus-eluting Prolim® Stent Registry

Sirolimus-eluting Stainless Steel Coronary Stent Prolim®
TriHealth Inc.

Completed

Long-term Usage of the Fitbit® Among Medical Residents

Continuous Fitbit® Use
National Institute of Mental Health (NIMH)

Completed

Pilot Study of Levetiracetam (Keppra® (Registered Trademark)) for Bipolar Illness

Bipolar Disorder

United States
Galderma R&D

Completed

ORCA - Oracea® for Rosacea: A Community-based Assessment

Rosacea

United States
King Abdulaziz University

Completed

Effect of Carriere® Motion™ Appliance on Airway Dimensions

Effect of Carriere® Motion™ Appliance on Pharyngeal Airway Dimensions | Effect of Carriere® Motion™ Appliance on Skeletal and Dental Measurements

Saudi Arabia
University of Chicago

Active, not recruiting

Thirty Million Words Home Visiting (TMW HV RCT)

Language Environments of Children of Low-socioeconomic Status

United States
Yale University

Completed

Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients. (Keppra)

Opioid Dependence | Cocaine Dependence

United States
Duquesne University
OsteoStrong

Active, not recruiting

Melatonin and Osteogenic Loading on Osteopenia (MelaOstrong)

Osteopenia

United States
Piramal Enterprises Limited
Profil Institute for Clinical Research, Inc.

Completed

Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects

Healthy

United States
Göteborg University

Recruiting

Effectiveness of Meshed Free Gingival Graft for Widening of Keratinized Tissues

Gingiva Atrophy

United Arab Emirates
University of Pittsburgh
Merck Sharp & Dohme LLC; RTI International; Rite Aid Corp.; Pharmacy Quality Alliance

Completed

Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications (ECO-PHIL)

Medication Adherence

United States
Hadassah Medical Organization

Completed

Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth.

Pulpotomies Primary Teeth | Effectiveness of MedCem MTA® in Pulpotomies Primary Teeth

Israel
UCB Pharma

Completed

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Epilepsy | Generalized Tonic-clonic Seizures

Japan
Seoul National University Hospital

Unknown

Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients

Glioblastoma Multiforme
A.A. Partners, LLC

Unknown

3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects (3-D-TEBE)

Bone Defects

Ukraine
B.Braun Médical - CoE Chasseneuil

Not yet recruiting

The Performance / Safety of the Celsite® Venous Access Ports (CAP)

The Performance / Safety of the Celsite® Venous Access Ports
UCB Pharma

Completed

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Epilepsy
UCB Pharma

Completed

S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Epilepsy
UCB Pharma

Completed

A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures

Absence Seizures
Hadassah Medical Organization

Completed

Assessment of the Effectiveness of Biodentine® in Pulpotomies Primary Teeth

Effectiveness of Biodentine® in Pulpotomies Primary Teeth

Israel
UCB Pharma

Completed

UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)

Epilepsy | Pregnancy Complications | Seizures | Birth Defects

United States
Southwestern Regional Medical Center

Completed

Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy

Carcinoma, Non-Small-Cell Lung

United States
UCB Pharma

Completed

Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy

Generalized Epilepsy
Children's Hospital Medical Center, Cincinnati

Completed

Dosing of Levetiracetam (Keppra) in Neonates

Seizures

United States
Pró Circulação®

Completed

Training-induced Muscle Strength and Its Role in Interface Pressure in Inelastic Compression

Resistance Training

Brazil
RAND

Completed

Evaluation of the Effectiveness of a Home Visiting Program for New Parents in New Mexico

Infant Health Risk Factors

United States
UCB Pharma
UCB Japan Co. Ltd.

Completed

Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method

Epilepsy
UCB Pharma

Completed

Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures

Epilepsy
UCB Pharma

Completed

Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy

Epilepsy
UCB Pharma

Completed

Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)

Anxiety Disorders

3

Subscribe